General - Kidney Stone Disease
Device Kidney Stone Disease
General payments
$1,051,165
Research payments
$92,946
Through program year 2022, $1,051,165 in general payments and $92,946 in research payments were reported against General - Kidney Stone Disease (Kidney Stone Disease).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $356,739 | 43 |
| 2022 | Research | $8,000 | 1 |
| 2021 | General | $48,998 | 44 |
| 2021 | Research | $39,945 | 1 |
| 2020 | General | $579,588 | 741 |
| 2020 | Research | $45,001 | 2 |
| 2019 | General | $65,839 | 100 |
Breakdown
The top 5 of 38 recipients; each share is of general payments naming this product in 2022.
Each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
The top 5 of 16 states; each share is of general payments naming this product in 2022 where a state was reported.
Records
928 general · 4 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.